Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

38.10
+1.173.17%
Post-market: 38.00-0.1000-0.26%19:59 EDT
Volume:5.28M
Turnover:199.59M
Market Cap:44.39B
PE:63.50
High:38.11
Open:37.13
Low:37.09
Close:36.93
52wk High:38.11
52wk Low:17.82
Shares:1.17B
Float Shares:1.09B
Volume Ratio:1.00
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.73
PE(LYR):31.49

Loading ...

May 07, 2025

Major Issues Report

Form 8-K - Current report
Apr 15, 2025

Correspondence

Form CORRESP - Correspondence
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]